Many primary demyelinating diseases, as observed in Multiple Sclerosis and the Guillain-Barre Syndrome, are widely regarded as due to immunologic processes, in which myelin serves as a target of immune attack. The mechanism(s) by which myelin breakdown is initiated and the damaged myelin is disposed of under these circumstances is poorly understood. In prior research, studies on MS and animal models of demyelination have tended to emphasize the identification and enumeration of immunologically active cells, Ab subtypes and elucidation of """"""""demyelinating Ab or Ab-like factors"""""""" participating in demyelination. Now, the time has clearly come to investigate the problems of demyelination at a more fundamental level to understand the mechanisms of myelin destruction by complement (C), cytotoxic T-cells, NK-cells or K-cells, and macrophages because these effectors are likely generated in inflammatory demyelination and their roles have been implicated in the pathogenesis of myelin destruction. The overall objective of this application is to define the biochemical events of demyelination. Particular stress placed on the role of channels formed on the membranes of myelin/oligodendrocytes. Efforts will also be made to develop an unifying concept of demyelination that can embrace other effectors like cytotoxic T-cells, NK-cells and K-cells since channels on target membranes is a shared mechanism among C, cytotoxic T-cells and NK cells. Macrophage cytotoxic factor which was found to be as cytotoxic to oligodendrocytes (Prelim. Results) will also be studied. Specifically, we will examine whether C channel formation on oligodendrocytes and/or myelin triggers activation of Ca++-dependent myelin neutral proteases. Ca++, lipid-dependent protein kinase C, production and release of arachidonic acid and its metabolites and membrane lipid methyltransferases. The metabolic consequence of activation of these enzymes such as proteolysis of BP and myelin associated glycoproteins in relation to the process of myelin destruction will be investigated.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Project (R01)
Project #
5R01NS015662-09
Application #
3396393
Study Section
Neurology C Study Section (NEUC)
Project Start
1979-07-01
Project End
1993-02-28
Budget Start
1988-03-01
Budget End
1989-02-28
Support Year
9
Fiscal Year
1988
Total Cost
Indirect Cost
Name
University of Maryland Baltimore
Department
Type
Schools of Medicine
DUNS #
003255213
City
Baltimore
State
MD
Country
United States
Zip Code
21201
Weerth, Susanna H; Rus, Horea; Shin, Moon L et al. (2003) Complement C5 in experimental autoimmune encephalomyelitis (EAE) facilitates remyelination and prevents gliosis. Am J Pathol 163:1069-80
Niculescu, Teodora; Weerth, Susanna; Soane, Lucian et al. (2003) Effects of membrane attack complex of complement on apoptosis in experimental autoimmune encephalomyelitis. Ann N Y Acad Sci 1010:530-3
Rus, H G; Niculescu, F I; Shin, M L (2001) Role of the C5b-9 complement complex in cell cycle and apoptosis. Immunol Rev 180:49-55
Soane, L; Cho, H J; Niculescu, F et al. (2001) C5b-9 terminal complement complex protects oligodendrocytes from death by regulating Bad through phosphatidylinositol 3-kinase/Akt pathway. J Immunol 167:2305-11
Niculescu, F; Soane, L; Badea, T et al. (1999) Tyrosine phosphorylation and activation of Janus kinase 1 and STAT3 by sublytic C5b-9 complement complex in aortic endothelial cells. Immunopharmacology 42:187-93
Soane, L; Rus, H; Niculescu, F et al. (1999) Inhibition of oligodendrocyte apoptosis by sublytic C5b-9 is associated with enhanced synthesis of bcl-2 and mediated by inhibition of caspase-3 activation. J Immunol 163:6132-8
Noe, K H; Cenciarelli, C; Moyer, S A et al. (1999) Requirements for measles virus induction of RANTES chemokine in human astrocytoma-derived U373 cells. J Virol 73:3117-24
Cheng, G; Nazar, A S; Shin, H S et al. (1998) IP-10 gene transcription by virus in astrocytes requires cooperation of ISRE with adjacent kappaB site but not IRF-1 or viral transcription. J Interferon Cytokine Res 18:987-97
Kim, Y U; Rus, H G; Fisher, S N et al. (1996) Binding of a protein to an AU-rich domain of tumour necrosis factor alpha mRNA as a 35 kDa complex and its regulation in primary rat astrocytes. Biochem J 316 ( Pt 2):455-60
Lokuta, M A; Maher, J; Noe, K H et al. (1996) Mechanisms of murine RANTES chemokine gene induction by Newcastle disease virus. J Biol Chem 271:13731-8

Showing the most recent 10 out of 39 publications